Amaran Biotech
Taipei, Taiwan· Est.
Taiwan CDMO delivering automated aseptic filling, adjuvant production and full‑service biopharma manufacturing.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Taiwan CDMO delivering automated aseptic filling, adjuvant production and full‑service biopharma manufacturing.
VaccinesBiologics
Technology Platform
Automated robotic aseptic filling line combined with GMP‑certified process development, adjuvant (QS‑21) production, and comprehensive analytical services.
Opportunities
Rising global demand for vaccine adjuvants and high‑precision aseptic filling, plus expansion into Water‑for‑Injection services, offers strong growth potential.
Risk Factors
Intense competition from larger Asian CDMOs, regulatory compliance complexity, and capital requirements for facility expansion.
Competitive Landscape
Competes with regional CDMOs such as WuXi, Samsung Biologics, and Lonza, differentiating through automated robotic filling and a focus on adjuvant manufacturing.